Cargando…
PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
Autores principales: | Orazem, M., Zumer, B., Segedin, B., Marinko, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629147/ http://dx.doi.org/10.1016/S0167-8140(21)07914-7 |
Ejemplares similares
-
PO-1451 Unintentional effects of societal restrictions during the SARS-CoV-2 pandemic on referral for RT B. Mortensen1
por: Mortensen, B.
Publicado: (2021) -
PO-1464 Impact of COVID-19 on Radiation Oncology, an Austrian Experience
por: Mangesius, J., et al.
Publicado: (2021) -
PO-1454 Reduction in radiotherapy episodes as a result of the COVID-19 pandemic
por: Mee, T., et al.
Publicado: (2021) -
PO-1461 Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil
por: Yoshinari Jr, G.H., et al.
Publicado: (2021) -
PO-1453 Covid-19 pandemic adapted radiotherapy guidelines: are they really followed?
por: Galofaro, E., et al.
Publicado: (2021)